|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Mildcognitiveimpairment:Cclinicalcharacterizationandoutcome-显示文摘 | PetersenRC SmithGE WaringSC etal | 1999 | Arch-Neural1999，56，3： | 1 |
| 2 | Endotoxin release platelet activating factor from human monocytes in vitro显示文摘 | Leaver AH Qu JM SmithG | 1990 | Immunopharmacology1990，20，： | 1 |
| 3 | Alcohol imake and blood pressure: a systematic review implementing a mendel ian randomizalion approach 显示文摘 | Chenl Smithg D Harbord RM | 2008 | Plos Med2008，5，3： | 1 |
| 4 | mu-Opioidreceptorstimulation of inositol(1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein显示文摘 | SmartD SmithG LambertDG | 1994 | J Neurochem1994，62，3： | 1 |
| 5 | Incidence of type2 diabetes in the randomized multiple risk factor interven-tion trial显示文摘 | Davey SmithG BrachaY Svendsen KH | 2005 | Ann Intern Med2005，142，5： | 1 |
| 6 | Mild cognitiveimpairment:Clinical characterization and outcome显示文摘 | PetersenRC SmithGE WaringSC | 1999 | Arch Neurol1999，56，3： | 1 |
| 7 | Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy:a prospective clinical study显示文摘 | MARIAPPAN P SMITHG BARIOL SV | 2005 | J Urol2005，173，： | 1 |
| 8 | Local uravesical BCG treutmirt If larcinoma显示文摘 | EL-Dimiry MIM Smithg G Richie AWS | 2005 | Term2005，10，9： | 1 |
| 9 | 1 Mild cognitive impairment clinical charac- terization and outcome显示文摘 | PetersenRC SmithGE WaringSC et a | 1999 | ArchNeurology1999，56，3： | 1 |
| 10 | Cellularchangesfromgradedtesticularischemia显示文摘 | SmithG | 1995 | Urol1995，73，： | 1 |
| 11 | Theidentificationofaminimalfeedbackvertexsetofadirectedgraph显示文摘 | SmithG W WalfordRBJr | 1975 | IEEE Transactionon CircuitsandSystems1975，22，1： | 1 |
| 12 | Theroleofthegutinthedevelopmentofsepsisinacutepancreatitis显示文摘 | RunkelN MoodyFG SmithGS etal | 1991 | JSurgRes,1991，51，1： | 1 |
| 13 | Ocalimmuno responses after intravesical BCG treatment of carcinoma in situ显示文摘 | EI-DemiryMIM SmithG RitchigAWS | 1987 | Brit J Urol1987，60，3： | 1 |
| 14 | Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation显示文摘 | SmithG Achola KJ | 1987 | Br J Ahaesth1987，59，： | 1 |
| 15 | Measuringneutronfluencesandgamma/X-rayfluxeswithCCDcameras显示文摘 | YatesGJ SmithG ZagarinoP etal | 1992 | IEEETransonNuclearScience1992，39，5： | 1 |
| 16 | Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation 显示文摘 | Shribman AJ SmithG Achola KJ | 1987 | Br J Anaesth1987，59，3： | 1 |
| 17 | Mildcognitiveimpairment: clinical characterization and outcome显示文摘 | PetersenRC SmithGE WaringSC etal | 1999 | Arch Neurol1999，56，3： | 1 |
| 18 | 介电弛豫光谱学及其在药学中的应用显示文摘介电弛豫光谱学(DRS)对分子运动及结构敏感,对样品无损,为了测定样品性质,仅需应用弱电磁场。该技术覆盖宽带频率窗(从10(-5)~10(11)Hz),可研究各种过程,从缓慢受阻的大分子振动,到小分子或侧链基团的相对快速重取向。介电响应可提供如下信息:聚合物、凝胶、蛋白质、乳状液的结构特性;分子膜的界面性质;膜性能;水含量及所处的状态;生物分子的冷冻干燥。本文详述介电理论的基础及测量介电性质的原理,并介绍DRS在药学领域的一些应用。 | SmithG 王晋 | 1996 | 国外医学(药学分册)1996，23，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员